01Celularity Inc filed a proxy statement on November 10, 2026, ahead of its annual shareholder meeting to disclose board nominations, executive compensation, and voting proposals.
02The healthcare company's stock trades at $0.71 with a market capitalization of $39.9 million as of the filing date.
03SEC filings like proxy statements provide mandatory disclosures that make material company information publicly available to all investors through the EDGAR database.
Filing Details
Celularity Inc (NASDAQ:CELU) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on November 10, 2026.
The Healthcare company's proxy statement provides information for shareholders ahead of the annual meeting, including board nominations, executive compensation, and proposals for shareholder vote.
Market Context
Celularity Inc's stock currently trades at $0.71 with a market capitalization of $39.9M.
SEC filings provide mandatory disclosures that give investors access to the same material information available to institutional investors. Reviewing Celularity Inc's filings alongside price action and analyst commentary provides a more complete picture of the company's current situation.
All SEC filings for Celularity Inc are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
What types of SEC filings does Celularity Inc file?
Public companies like Celularity Inc file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.